CGREX | CSSPX | CGREX / CSSPX | |
Total Expense Ratio | 2.17 | 0.90 | 241% |
Annual Report Gross Expense Ratio | 2.17 | 0.93 | 233% |
Fund Existence | 20 years | 28 years | - |
Gain YTD | 5.649 | 8.577 | 66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 135M | 1.99B | 7% |
Annual Yield % from dividends | 1.29 | 2.83 | 46% |
Returns for 1 year | 8.14 | 11.37 | 72% |
Returns for 3 years | -7.12 | 12.69 | -56% |
Returns for 5 years | -3.03 | 33.27 | -9% |
Returns for 10 years | -12.27 | 51.23 | -24% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTCHX | 66.08 | 0.94 | +1.44% |
Invesco Technology Investor | |||
VNVAX | 24.31 | 0.20 | +0.83% |
Natixis Vaughan Nelson Mid Cap A | |||
AXVIX | 18.20 | 0.10 | +0.55% |
Acclivity Small Cap Value I | |||
FBDIX | 117.80 | 0.59 | +0.50% |
Franklin Biotechnology Discovery A | |||
HSWCX | 20.31 | 0.03 | +0.15% |
Hartford Schroders International Stk C |